Best products for your love one

The drug, Aduhelm, a monthly infusion priced at $56,000 per year, was approved this week despite weak evidence that it helps patients : Health


Over the past 25 years, pharmaceutical companies deceptively promoted opioid use and other new drugs in ways that were often neither safe nor effective, contributing to unprecedented increases in prescribing, opioid use disorder, and deaths by overdose. The regulatory mistakes made by the US Food and Drug Administration (FDA) in approving and labeling new analgesics contributed to the public health crises and this article is an example of the improper pharmaceutical marketing and their use of the FDA advisers to get their drugs approved.


Source link

We will be happy to hear your thoughts

Leave a reply

Enable registration in settings - general
Compare items
  • Total (0)